Skip to menu Skip to content Skip to footer

2011

Journal Article

Noninvasive tools to assess liver disease

Clark, Paul J. and Patel, Keyur (2011). Noninvasive tools to assess liver disease. Current Opinion in Gastroenterology, 27 (3), 210-216. doi: 10.1097/MOG.0b013e328343e9a3

Noninvasive tools to assess liver disease

2011

Journal Article

IL28B polymorphisms and treatment of hepatitis C

Clark, Paul J., Thompson, Alexander J. V. and Muir, Andrew J. (2011). IL28B polymorphisms and treatment of hepatitis C. Current Hepatitis Reports, 10 (1), 70-78. doi: 10.1007/s11901-010-0061-3

IL28B polymorphisms and treatment of hepatitis C

2011

Journal Article

IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: The future of personalized HCV therapies

Clark, Paul J., Thompson, Alex J. and McHutchison, John G. (2011). IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: The future of personalized HCV therapies. American Journal of Gastroenterology, 106 (1), 38-45. doi: 10.1038/ajg.2010.370

IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: The future of personalized HCV therapies

2011

Journal Article

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR

Thompson, Alexander J., Santoro, Rosanna, Piazzolla, Valeria, Clark, Paul J., Naggie, Susanna, Tillmann, Hans L., Patel, Keyur, Muir, Andrew J., Shianna, Kevin V., Mottola, Leonardo, Petruzzellis, Daniela, Romano, Mario, Sogari, Fernando, Facciorusso, Domenico, Goldstein, David B., McHutchison, John G. and Mangia, Alessandra (2011). Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR. Hepatology, 53 (2), 389-395. doi: 10.1002/hep.24068

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR

2010

Journal Article

Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype

Thomison, Allxander J., Muir, Andrew J., Sulkowski, Mark. S., Path, Keyur, Jilimann, Hans L., Clark, Paul J., Naccie, Susanna, Fellay, Jacques, Ge, Dongliang, McCarthy, Jlanlite J., Goldslin, David B. and McHutchison, John G. (2010). Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype. Hepatology, 52 (6), 2243-2244. doi: 10.1002/hep.23826

Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype

2010

Journal Article

Hepatitis C virus nonstructural protein 5A inhibitors: Novel target - Now for new trials and new treatment strategies

Thompson, Alex J., Clark, Paul J. and McHutchison, John G. (2010). Hepatitis C virus nonstructural protein 5A inhibitors: Novel target - Now for new trials and new treatment strategies. Hepatology, 52 (3), 1162-1164. doi: 10.1002/hep.23853

Hepatitis C virus nonstructural protein 5A inhibitors: Novel target - Now for new trials and new treatment strategies

2010

Journal Article

The diagnosis and management of hereditary haemochromatosis

Clark, Paul, Britton, Laurence J. and Powell, Lawrie W. (2010). The diagnosis and management of hereditary haemochromatosis. Clinical Biochemist Reviews, 31 (1), 3-8.

The diagnosis and management of hereditary haemochromatosis

2010

Journal Article

Genetic variation in IL28B: Impact on drug development for chronic hepatitis C infection

Clark, P. J., Thompson, A. J. V. and McHutchison, J. G. (2010). Genetic variation in IL28B: Impact on drug development for chronic hepatitis C infection. Clinical Pharmacology and Therapeutics, 88 (5), 708-711. doi: 10.1038/clpt.2010.185

Genetic variation in IL28B: Impact on drug development for chronic hepatitis C infection

2008

Journal Article

Utility of eosinophilia as a diagnostic clue in lower abdominal pain in northern Australia: a retrospective case-control study

Clark, P. J. (2008). Utility of eosinophilia as a diagnostic clue in lower abdominal pain in northern Australia: a retrospective case-control study. Internal Medicine Journal, 38 (4), 278-280. doi: 10.1111/j.1445-5994.2008.01644.x

Utility of eosinophilia as a diagnostic clue in lower abdominal pain in northern Australia: a retrospective case-control study

2007

Journal Article

Resolution of protein-losing enteropathy after successful heart transplantation in an adult patient with arrhythmogenic right ventricular cardiomyopathy (ARVC)

Korczyk, Darius, Clark, Paul, Crawford, Darrell, Maddicks-Law, Jo, Javorsky, George and Meyers, Deborah (2007). Resolution of protein-losing enteropathy after successful heart transplantation in an adult patient with arrhythmogenic right ventricular cardiomyopathy (ARVC). Journal of Heart and Lung Transplantation, 26 (9), 963-964. doi: 10.1016/j.healun.2007.07.003

Resolution of protein-losing enteropathy after successful heart transplantation in an adult patient with arrhythmogenic right ventricular cardiomyopathy (ARVC)

2006

Journal Article

Changing patterns of tuberculosis in Far North Queensland

Simpson, G, Clark, P and Knight, T (2006). Changing patterns of tuberculosis in Far North Queensland. Medical Journal of Australia, 184 (5), 252-252.

Changing patterns of tuberculosis in Far North Queensland

1940

Journal Article

Effect on the prostate gland of occlusion of its ducts

Huggins, C and Clark, PJ (1940). Effect on the prostate gland of occlusion of its ducts. Archives of Pathology, 30 (6), 1178-1183.

Effect on the prostate gland of occlusion of its ducts

1940

Journal Article

Quantitative studies of prostatic secretion II. The effect of castration and of estrogen injection on the normal and on the hyperplastic prostate glands of dogs

Huggins, C and Clark, PJ (1940). Quantitative studies of prostatic secretion II. The effect of castration and of estrogen injection on the normal and on the hyperplastic prostate glands of dogs. Journal of Experimental Medicine, 72 (6), 747-U11. doi: 10.1084/jem.72.6.747

Quantitative studies of prostatic secretion II. The effect of castration and of estrogen injection on the normal and on the hyperplastic prostate glands of dogs